Daiichi Sankyo, Inc. - Exhibitor









Company Website

Contact Information:

Celina Raider
Cell:  480-201-8798

Candice Bradford
Cell: 480-822-8110


Virtual Exhibit Hall Home


Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast cancer, gastric cancer, tenosynovial giant cell tumor, hypertension, dyslipidemia, diabetes, thrombosis, stroke risk reduction, acute coronary syndrome, and IV iron therapy.


Iron Deficiency Product Website